747408
Iron oxide(II,III), magnetic nanoparticles solution
30 nm avg. part. size (TEM), PEG functionalized, dispersion, 1 mg/mL Fe in H2O
Synonyme(s) :
Fe NP PEG, FexOy, Magnetic iron oxide nanocrystals, Magnetite, Superparamagnetic iron oxide nanoparticles
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
Formule empirique (notation de Hill) :
Fe3O4
Numéro CAS:
Poids moléculaire :
231.53
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12352302
MDL number:
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderQuality Level
form
dispersion, nanoparticles
concentration
1 mg/mL Fe in H2O
magnetization
>45 emu/g (at room temperature; under 4500 Oe)
color
black
avg. part. size
30 nm (TEM)
density
0.988 g/mL at 25 °C, ~1 g/mL at 25 °C
functional group
PEG
storage temp.
2-8°C
SMILES string
O=[Fe].O=[Fe]O[Fe]=O
InChI
1S/3Fe.4O
InChI key
SZVJSHCCFOBDDC-UHFFFAOYSA-N
General description
Concentration 5mg/ml includes total weight nanocrystals plus ligands.
Application
These magnetic nanoparticles are typically used in imaging or as contrast agents. The surface functionality allows for different ligation or further functionalization.
Do not freeze.
Do not freeze.
Legal Information
Product of Supplier: OCEAN NANOTECH LLC
Classe de stockage
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Faheem Muhammad et al.
Colloids and surfaces. B, Biointerfaces, 123, 506-514 (2014-12-03)
Simultaneous delivery of multiple therapeutic agents is of great importance for effective chemotherapy due of its well-known drug synergism and suppression to chemoresistance. We report a new theranostic nanoformulation to shuttle multiple chemotherapeutic agents for successfully exterminating cancer cells. This
Tianyuzi Li et al.
International journal of nanomedicine, 10, 3779-3790 (2015-06-18)
Regimen adherence, systemic toxicities, and limited drug penetrance to viral reservoirs are obstacles limiting the effectiveness of antiretroviral therapy (ART). Our laboratory's development of the monocyte-macrophage-targeted long-acting nanoformulated ART (nanoART) carriage provides a novel opportunity to simplify drug-dosing regimens. Progress
Aaron Harman et al.
Journal of computer assisted tomography, 38(4), 571-573 (2014-04-16)
Ferumoxytol is a parenteral iron therapy that the Food and Drug Administration recently approved for the treatment of iron-deficiency anemia. The form of the iron, ultrasmall superparamagnetic iron oxide nanoparticles, causes T1, T2, and T2* shortening on magnetic resonance imaging